CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 801 - 810 of 842
Study Number Lead Group Study Title CIRB Study Status
AALL15P1 COG A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement Pediatric CIRB Available to Open
10246 ETCTN A Phase 1 Study of MLN4924 (pevonedistat) and Belinostat in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Adult CIRB - Early Phase Emphasis Available to Open
EA6141 ECOG-ACRIN Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma Adult CIRB - Late Phase Emphasis Available to Open
ABTC-1801 ABTC Phase I/II Study of Pamiparib (BGB-290) with Temozolomide in Recurrent Gliomas with IDH1/2 Mutations Adult CIRB - Early Phase Emphasis Available to Open
9903 ETCTN A Phase 1B Study of AZD9291 in Combination with Navitoclax in EGFR-mutant Non-Small Cell Lung Cancer Following Resistance to Initial EGFR Kinase Inhibitor Adult CIRB - Early Phase Emphasis Available to Open
10329 ETCTN Phase I Sequential Trial of Agents Against DNA Repair (STAR) Adult CIRB - Early Phase Emphasis Available to Open
NRG-LU001 NRG Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC Adult CIRB - Late Phase Emphasis Available to Open
EA8185 ECOG-ACRIN Phase 2 Study of Bladder-SparIng ChemoradiatioN with MEDI4736 (Durvalumab) in clinical Stage 3, Node PosItive bladdeR cancEr (INSPIRE) Adult CIRB - Late Phase Emphasis Available to Open
RTOG-0724 RTOG Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy Adult CIRB - Late Phase Emphasis Available to Open
MDA2014-04-02 CLO-MD Anderson VADIS Trial: Phase II trial of Nelipepimut-S Peptide Vaccine in Women with DCIS of the Breast Cancer Prevention and Control CIRB Available to Open
Displaying 801 - 810 of 842